ARCHIVES

Perifosine, Sorafenib Combination Well Tolerated in Several Lymphomas

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | December 28, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Little Doubt That DeVita, Frederickson Will Keep Their Jobs; New DCT Projects May Not Be Funded

March 6, 1981

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

April 26, 2013

Telatinib Demonstrates Positive Results in First-Line Treatment

June 24, 2011

Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease

June 29, 2012

Studies On Diet Add To Information On Fiber, Fat, Meat

April 5, 1991

Barakat Named Deputy Physician-in-Chief Of Memorial Sloan-Kettering’s Regional Care Network

October 18, 2013